Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/55010
Citations
Scopus Web of ScienceĀ® Altmetric
?
?
Type: Journal article
Title: Trichilemmal carcinoma of the upper eyelid
Author: Lai, T.
Huilgol, S.
James, C.
Selva-Nayagam, D.
Citation: Acta Ophthalmologica, 2003; 81(5):536-538
Publisher: Wiley-Blackwell Munksgaard
Issue Date: 2003
ISSN: 1755-375X
1600-0420
Statement of
Responsibility: 
Tze Foon Lai, Shyamala C. Huilgol, Craig L. James and Dinesh Selva
Abstract: <h4>Introduction</h4>Trichilemmal carcinoma (TLC) is a rare adnexal tumour related to the external hair sheath. We describe the first case of TLC on the upper eyelid to be treated with Mohs micrographic surgery.<h4>Case report</h4>A 65-year-old man presented with a 2-month history of a firm 4 mm left upper eyelid nodule. An incisional biopsy revealed an infiltrative, lobulated tumour composed of large, polygonal, clear cells. A diagnosis of trichilemmal carcinoma was made and the patient underwent Mohs micrographic surgery. At follow-up 2 years later, there was no evidence of recurrence.<h4>Conclusion</h4>The pathogenesis of TLC remains unclear, with actinic damage, longterm low dose irradiation and transformation from benign trichilemmoma having been postulated. Trichilemmal carcinomas must be differentiated from other malignant clear cell tumours of the eyelid and the correct diagnosis made promptly as TLC takes an indolent clinical course, in which metastasis is a rare event, despite the tumour's cytologically malignant appearance. We recommend Mohs micrographic surgery as a treatment modality for this tumour, due to its potential for locally aggressive growth and local recurrence.
Keywords: trichilemmal carcinoma
eyelid
Mohs micrographic surgery
DOI: 10.1034/j.1600-0420.2003.00132.x
Published version: http://dx.doi.org/10.1034/j.1600-0420.2003.00132.x
Appears in Collections:Aurora harvest 5
Medicine publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.